Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | LDHA | P00338 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9842022 | 0.83 | SIGMAR1 (0.41) | KMT2A | |
| SCHEMBL5190544 | 0.80 | ALDH1A1 (0.56) | ALDH1A1L3MBTL1LMNAMAPK1KMT2A | |
| SCHEMBL5190638 | 0.76 | ALDH1A1 (0.55) | ALDH1A1L3MBTL1LMNAMAPK1KMT2A | |
| SCHEMBL9842276 | 0.75 | MITF (0.47) | L3MBTL1KMT2AKDM4E | |
| SCHEMBL22639906 | 0.74 | TDP1 (0.57) | ALDH1A1L3MBTL1LMNAMAPK1KMT2A | |
| SCHEMBL22640056 | 0.74 | TDP1 (0.57) | ALDH1A1L3MBTL1LMNAMAPK1KMT2A | |
| SCHEMBL5190692 | 0.73 | ALDH1A1 (0.48) | ALDH1A1L3MBTL1LMNAMAPK1KMT2A | |
| SCHEMBL5192506 | 0.70 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1LMNAMAPK1KDM4E | |
| SCHEMBL9842327 | 0.70 | HTR6 (0.41) | ALDH1A1LMNA | |
| SCHEMBL8589350 | 0.69 | EBP (0.57) | POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0461264-A1 | ETHYNYLPHENYL DERIVATIVE, PRODUCTION THEREOF, AND REMEDY FOR DISEASES OF CIRCULATORY ORGANS CONTAINING THE SAME AS ACTIVE INGREDIENT | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 1991-12-18 | — | — | EP | disclosed |